RISS 검색 - 국내학술지논문 상세보기

다국어 초록 (Multilingual Abstract)

Background: Rare ginsenosides (F2, Rg3, Gyp- XVII, and C-K) are pharmaceutically active components of Panax ginseng, which are derived from the conversion of major ginsenosides through various transformation methods.
To date, most studies have failed to identify a competent bacterial strain and recombinant enzyme for converting protopanaxadiol (PPD)- and protopanaxatriol (PPT)-type ginsenosides to target minor ginsenosides. Method: Our study identified and employed nine sets of clones from different glycoside hydrolase bacterial strains for major ginsenoside bioconversion. Among these nine clones, only BglFc was selected based on its strong biotransformation ability and capacity to generate complete minor ginsenosides.
bglFc was cloned and expressed in Escherichia coli using the pGEX-4T-1 vector system, and the recombinant enzyme was used for efficiently producing minor ginsenosides.
Results: Recombinant BglFc is 2,394 bp and 798 amino acid residues long, with a predicted molecular mass of 78.8 kDa. BglFc belongs to the glycoside hydrolase family 3, and demonstrates a promising ability to convert major ginsenosides into minor ones. The Km and Vmax values of pNPG were 0.81 ± 0.06 and 4.0 ± 0.2 mM·min-1·mg-1 of protein, respectively. Under optimal conditions (37°C, pH 7.0), the ginsenoside transformation pathways for BglFc were as follows: Rb1→Rd→Rg3(S)→Rh2(S); GypXVII →GypLXXV→C-K; GypLXXV→C-K; F2→C-K; Rb2 →C-O→C-Y; Rb3→C-Mx1→C-Mx; Rc→C-Mc1→CMc; Re→Rg2(S); and Rg1→Rh1(S), respectively. Conclusion: These results suggest that recombinant BglFc demonstrates a strong transformation activity for both PPD- and PPTtype major ginsenosides. Therefore, we conclude that BglFc can be used for gram unit production of various minor ginsenosides. Significance and Impact of Study: Previously, researchers have used a combination of enzymes for the production of minor ginsenosides. However, in this study, we found a favorable enzyme that can be used alone for the production of a different type of minor ginsenoside using the proposed conversion pathway.

번역하기

참고문헌 (Reference)

1 배은아, "Transformation of Ginseng Saponins to Ginsenoside Rh2 by Acids and Human Intestinal Bacteria and Biological Activities of Their Transformants" 대한약학회 27 (27): 61-67, 2004

2 Saitou, N, "The neighbor-joining method: a new method for reconstructing phylogenetic trees" 4 : 406-425, 1987

3 Thompson, J. D, "The CLUSTAL_X windows interface:flexible strategies for multiple sequence alignment aided by quality analysis tools" 25 : 4876-4882, 1997

4 Kim, J. E, "Suppressive effects of rare ginsenosides, Rk1 and Rg5, on HMGB1-mediated septic responses" 124 : 45-53, 2019

5 Lee, W, "Suppressive activities of KC1-3 on HMGB1-mediated septic responses" 163 : 260-268, 2019

6 Wonhwa Lee, "Pulmonary Protective Functions of Rare Ginsenoside Rg4 on Particulate Matter-induced Inflammatory Responses" 한국생물공학회 24 (24): 445-453, 2019

7 Yoo, M. H, "Production of aglycon protopanaxadiol via compound K by a thermostable β-glycosidase from Pyrococcus furiosus" 89 : 1019-1028, 2011

8 Park Yeong-Ju, "Optimal bioconversion for compound K production from red ginseng root (C.A. Mayer) by sequential enzymatic hydrolysis and its characteristics" 한국응용생명화학회 64 (64): e0145876-, 2021

9 Sengupta, S, "Modulating angiogenesis: the yin and the yang in ginseng" 110 : 1219-1225, 2004

10 Tamura, K, "MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods" 28 : 2731-2739, 2011